Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
- Conditions
- Hematopoietic and Lymphatic System NeoplasmLeukemiaLymphoma
- Interventions
- Procedure: Allogeneic Hematopoietic Stem Cell TransplantationOther: Placebo Administration
- First Posted Date
- 2017-02-17
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 173
- Registration Number
- NCT03057054
- Locations
- πΊπΈ
Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids, Michigan, United States
πΊπΈUniversity of Wisconsin Carbone Cancer Center - University Hospital, Madison, Wisconsin, United States
πΊπΈChildren's Hospital of Alabama, Birmingham, Alabama, United States
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
- Conditions
- B Acute Lymphoblastic LeukemiaAcute Lymphoblastic LeukemiaMixed Phenotype Acute LeukemiaT Acute Lymphoblastic Leukemia
- Interventions
- Procedure: Allogeneic Hematopoietic Stem Cell TransplantationOther: Laboratory Biomarker AnalysisOther: Questionnaire Administration
- First Posted Date
- 2017-01-02
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 475
- Registration Number
- NCT03007147
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUSA Health Strada Patient Care Center, Mobile, Alabama, United States
πΊπΈProvidence Alaska Medical Center, Anchorage, Alaska, United States
Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
- Conditions
- Recurrent B Acute Lymphoblastic LeukemiaRecurrent B Lymphoblastic LymphomaRefractory B Acute Lymphoblastic LeukemiaRefractory B Lymphoblastic Lymphoma
- Interventions
- Procedure: Biospecimen CollectionProcedure: Bone Marrow Aspiration and BiopsyProcedure: Diagnostic ImagingProcedure: Lumbar Puncture
- First Posted Date
- 2016-12-05
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 80
- Registration Number
- NCT02981628
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈProvidence Alaska Medical Center, Anchorage, Alaska, United States
πΊπΈBanner Children's at Desert, Mesa, Arizona, United States
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
- Conditions
- Refractory Primary Central Nervous System NeoplasmChildhood Solid NeoplasmRefractory Malignant Solid NeoplasmRecurrent Malignant Solid NeoplasmRecurrent Primary Central Nervous System Neoplasm
- Interventions
- Other: Laboratory Biomarker AnalysisOther: Pharmacological Study
- First Posted Date
- 2016-11-29
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 33
- Registration Number
- NCT02975882
- Locations
- πΊπΈ
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
πΊπΈChildren's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈChildren's Hospital Los Angeles, Los Angeles, California, United States
Rituximab and LMP-Specific T-Cells in Treating Pediatric Solid Organ Recipients With EBV-Positive, CD20-Positive Post-Transplant Lymphoproliferative Disorder
- Conditions
- Refractory Monomorphic Post-Transplant Lymphoproliferative DisorderMonomorphic Post-Transplant Lymphoproliferative DisorderRecurrent Polymorphic Post-Transplant Lymphoproliferative DisorderEBV-Related Post-Transplant Lymphoproliferative DisorderPolymorphic Post-Transplant Lymphoproliferative DisorderRecurrent Monomorphic Post-Transplant Lymphoproliferative DisorderRefractory Polymorphic Post-Transplant Lymphoproliferative Disorder
- Interventions
- Biological: Allogeneic LMP1/LMP2-Specific Cytotoxic T-Lymphocytes
- First Posted Date
- 2016-09-15
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 18
- Registration Number
- NCT02900976
- Locations
- πΊπΈ
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
πΊπΈChildren's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
- Conditions
- B-Cell Non-Hodgkin LymphomaRecurrent Childhood Acute Lymphoblastic LeukemiaChildhood NeoplasmHematopoietic and Lymphoid Cell NeoplasmAcute Lymphoblastic LeukemiaChildhood Acute Myeloid LeukemiaChildhood Burkitt LymphomaMalignant Solid Neoplasm
- Interventions
- Other: Informational InterventionOther: InterviewOther: Medical Chart ReviewOther: Questionnaire Administration
- First Posted Date
- 2016-07-28
- Last Posted Date
- 2023-07-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 530
- Registration Number
- NCT02847130
- Locations
- πΊπΈ
Kaiser Permanente-Oakland, Oakland, California, United States
πΊπΈAlfred I duPont Hospital for Children, Wilmington, Delaware, United States
πΊπΈGolisano Children's Hospital of Southwest Florida, Fort Myers, Florida, United States
Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
- Conditions
- Refractory Malignant Solid NeoplasmRecurrent Primary Central Nervous System NeoplasmChildhood Solid NeoplasmRecurrent Malignant Solid NeoplasmRefractory Primary Central Nervous System Neoplasm
- Interventions
- First Posted Date
- 2016-06-22
- Last Posted Date
- 2023-12-20
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 30
- Registration Number
- NCT02808650
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
πΊπΈChildren's Hospital Los Angeles, Los Angeles, California, United States
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma
- Conditions
- Medulloblastoma
- Interventions
- Other: Laboratory Biomarker AnalysisProcedure: Magnetic Resonance ImagingRadiation: Radiation Therapy
- First Posted Date
- 2016-03-31
- Last Posted Date
- 2025-06-11
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 45
- Registration Number
- NCT02724579
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈUSA Health Strada Patient Care Center, Mobile, Alabama, United States
πΊπΈProvidence Alaska Medical Center, Anchorage, Alaska, United States
Carvedilol in Preventing Heart Failure in Childhood Cancer Survivors
- Conditions
- Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm
- Interventions
- Other: Laboratory Biomarker AnalysisOther: Pharmacological StudyOther: Pharmacogenomic StudyOther: Placebo AdministrationOther: Quality-of-Life AssessmentOther: Questionnaire Administration
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 196
- Registration Number
- NCT02717507
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
πΊπΈArkansas Children's Hospital, Little Rock, Arkansas, United States
Liposome-encapsulated Daunorubicin-Cytarabine, Fludarabine Phosphate, Cytarabine, and Filgrastim in Treating Younger Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Conditions
- Acute Myeloid Leukemia Post Cytotoxic TherapySecondary Acute Myeloid LeukemiaRecurrent Childhood Acute Myeloid Leukemia
- Interventions
- Biological: FilgrastimOther: Laboratory Biomarker AnalysisDrug: Liposome-encapsulated Daunorubicin-CytarabineOther: Pharmacological Study
- First Posted Date
- 2015-12-30
- Last Posted Date
- 2023-09-08
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 38
- Registration Number
- NCT02642965
- Locations
- πΊπΈ
Children's Hospital of Alabama, Birmingham, Alabama, United States
πΊπΈPhoenix Childrens Hospital, Phoenix, Arizona, United States
πΊπΈArkansas Children's Hospital, Little Rock, Arkansas, United States